Rafael Rotaeche

Prof. Rafael Rotaeche

Osakidetza, Vitoria-Gasteiz, Basque Country, Spain
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Primary Care Diabetes
Verified
Journal Article
Closed access
EMEstibaliz Gamboa Moreno
Estibaliz Gamboa Moreno
MMMaider Mateo-Abad
Maider Mateo-Abad
LGLourdes Ochoa de Retana García
Lourdes Ochoa de Retana García
KVKalliopi Vrotsou
Kalliopi Vrotsou
EPEmma del Campo Pena
Emma del Campo Pena
RRRafael Rotaeche
Rafael Rotaeche

23 March 2023 in BMC Primary Care
Verified
Journal Article
Open access
PDF file
JMJesus Martín-Fernández
Jesus Martín-Fernández
TATamara Alonso-Safont
Tamara Alonso-Safont
EPELENA POLENTINOS-CASTRO
ELENA POLENTINOS-CASTRO
MEMaria Dolores Esteban-Vasallo
Maria Dolores Esteban-Vasallo
GAGloria Ariza-Cardiel
Gloria Ariza-Cardiel
ABAmaia Bilbao-González
Amaia Bilbao-González
Background: Hypertension is responsible for a huge burden of disease. The aim of this study was to evaluate the impact of newly diagnosed hypertension on the occurrence of kidney or cardiovascular events (K/CVEs) and on mortality among community dwellers. Methods: Retrospective cohort study, conducted from January, 2007, to December, 2018. All patients (age > 18) newly diagnosed with hypertension and no previous K/CVEs in 2007 and 2008, in the primary care centers of Madrid (Spain) (n = 71,770), were enrolled. The control group (n = 72,946) included patients without hypertension, matched by center, sex and age. The occurrence of kidney or CV events, including mortality from these causes and total mortality were evaluated using Cox regression and multistate models. Data were collected from three sources: personal data from administrative records, clinical data from medical records, and mortality data from regional and national databases. Results: The median follow-up was 138.61 months (IQR: 124.68–143.97 months). There were 32,896 K/CVEs (including 3,669 deaths from these causes) and 12,999 deaths from other causes. Adjusted for sex, smoking, diabetes and socioeconomic status, K/CVEs HR was 4.36 (95% CI: 3.80–5.00) for diagnoses before 45 years of age, 2.45(95% CI: 2.28- 2.63) for diagnosis between 45 to 54 years, and HR decreased to 1.86 (95% CI: 1.64–210) for diagnoses over age 85. Total mortality risk was only higher for hypertension diagnosed before 55 years of age (HR: 2.47, 95% CI: 1.90–3.19 for ages 18 to 44; and HR: 1.14, 95% CI: 1.02–1.28 for ages 45 to 54). Conclusion: The diagnosis of hypertension in the community environment, in patients without evidence of previous kidney or CV disease, is associated with a large increase in the risk of K/CVEs, but especially in individuals diagnosed before the age of 55. This diagnosis is only associated with an increase in kidney or cardiovascular mortality or overall mortality when it occurs before age 55.

24 October 2013 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
AEArritxu Etxeberria
Arritxu Etxeberria
IPItziar Pérez
Itziar Pérez
IAIdoia Alcorta
Idoia Alcorta
JEJose Ignacio Emparanza
Jose Ignacio Emparanza
EVElena Ruiz de Velasco
Elena Ruiz de Velasco
RRRafael Rotaeche
Rafael Rotaeche
The appropriate care for people with cardiovascular risk factors can reduce morbidity and mortality. One strategy for improving the care for these patients involves the implementation of evidence-based guidelines. To date, little research concerning the impact of such implementation strategies in our setting has been published. Aims. To evaluate the effectiveness of a multifaceted tailored intervention in the implementation of three cardiovascular risk-related guidelines (hypertension, type 2 diabetes and dyslipidemia) in primary care in the Basque Health Service compared with usual implementation.

8 February 2018 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
AEArritxu Etxeberria
Arritxu Etxeberria
IAIdoia Alcorta
Idoia Alcorta
IPItziar Pérez
Itziar Pérez
JEJose Ignacio Emparanza
Jose Ignacio Emparanza
EVElena Ruiz de Velasco
Elena Ruiz de Velasco
RRRafael Rotaeche
Rafael Rotaeche
The implementation of evidence-based clinical practice guidelines (CPG) can improve patients care. To date, the impact of implementation strategies has not been evaluated in our context. This study is aimed to evaluate the effectiveness of a multifaceted tailored intervention targeting clinician education for the implementation of three cardiovascular risk-related CPGs (type 2 diabetes, hypertension and dyslipidemia) in primary care at the Basque Health Service compared with usual implementation. We conducted a cluster randomized controlled trial in two urban districts with 43 primary care units (PCU). Data from all patients diagnosed with diabetes, hypertension and all those eligible for coronary risk (CR) assessment were included. In the control group, guidelines were introduced in the usual way (by email, intranet and clinical meetings). In the intervention group, the implementation also included a specific website and workshops. Primary endpoints were annual HbA1c testing (diabetes), annual general laboratory testing (hypertension) and annual CR assessment (dyslipidemia). Secondary endpoints were process, prescription and clinical endpoints related with guideline recommendations. Analysis was performed at a PCU level weighted by cluster size. Significant differences between groups were observed in primary outcomes in the dyslipidemia CPG: increased CR assessment for both women and men (weighted mean difference, WMD, 13.58 and 12.91%). No significant differences were observed in diabetes and hypertension CPGs primary outcomes. Regarding secondary endpoints, annual CR assessment was significantly higher in both diabetic and hypertensive patients in the intervention group (WMD 28.16 and 27.55%). Rates of CR assessment before starting new statin treatments also increased (WMD 23.09%), resulting in a lower rate of statin prescribing in low risk women. Diuretic prescribing was higher in the intervention group (WMD 20.59%). Clinical outcomes (HbA1c and blood pressure control) did not differ between groups. The multifaceted implementation proved to be effective to increase the CR assessment and to improve prescription, but ineffective to improve diabetes and hypertension related outcomes. In order to obtain real improvements when cardiovascular issues are tackled, perhaps other or additional interventions need to be implemented besides education of professionals. Current Controlled Trials, ISRCTN 88876909 (retrospectively registered on January 13, 2009)

15 May 2009 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
PAPablo Alonso
Pablo Alonso
ISIvan Solà
Ivan Solà
RRRafael Rotaeche
Rafael Rotaeche
AGAna Isabel González-González
Ana Isabel González-González
MMMercè Marzo-Castillejo
Mercè Marzo-Castillejo
CCCarlos Calderón
Carlos Calderón
The philosophy of evidence-based medicine (EBM) was introduced in the early 90s as a new approach to the practice of medicine, using the best available evidence to make decisions about health care. Despite ongoing controversy, EBM has developed enormously and physicians' attitude towards it is generally positive. Nevertheless, in Spain little is known about this topic. We will therefore undertake a study to explore perceptions, attitudes and knowledge about EBM among primary care physicians.

19 May 2013 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
MAMariam De La Poza Abad
Mariam De La Poza Abad
GDGemma Mas Dalmau
Gemma Mas Dalmau
MBMikel Moreno Bakedano
Mikel Moreno Bakedano
AGAna Isabel González-González
Ana Isabel González-González
YCYolanda Canellas Criado
Yolanda Canellas Criado
FGfor the Delayed Antibiotic Prescription (DAP) Working Group
for the Delayed Antibiotic Prescription (DAP) Working Group
Background: Respiratory tract infections are an important burden in primary care and it’s known that they are usually self-limited and that antibiotics only alter its course slightly. This together with the alarming increase of bacterial resistance due to increased use of antimicrobials calls for a need to consider strategies to reduce their use. One of these strategies is the delayed prescription of antibiotics. Methods: Multicentric, parallel, randomised controlled trial comparing four antibiotic prescribing strategies in acute non-complicated respiratory tract infections. We will include acute pharyngitis, rhinosinusitis, acute bronchitis and acute exacerbation of chronic bronchitis or chronic obstructive pulmonary disease (mild to moderate). The therapeutic strategies compared are: immediate antibiotic treatment, no antibiotic treatment, and two delayed antibiotic prescribing (DAP) strategies with structured advice to use a course of antibiotics in case of worsening of symptoms or not improving (prescription given to patient or prescription left at the reception of the primary care centre 3 days after the first medical visit). Discussion: Delayed antibiotic prescription has been widely used in Anglo-Saxon countries, however, in Southern Europe there has been little research about this topic. The DAP trial wil evaluate two different delayed strategies in Spain for the main respiratory infections in primary care. Trial registration: This trial is registered with ClinicalTrials.gov, number http://NCT01363531.